Company registration number 08312723 (England and Wales)
GUILDHEALTH LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024
PAGES FOR FILING WITH REGISTRAR
GUILDHEALTH LIMITED
COMPANY INFORMATION
Directors
A J Fowles
D J Hudson
B J Jenkins
D Butler
Company number
08312723
Registered office
128 Buckingham Palace Road
London
United Kingdom
SW1W 9SA
Auditor
Azets Audit Services
2nd Floor
Regis House
45 King William Street
London
EC4R 9AN
GUILDHEALTH LIMITED
CONTENTS
Page
Directors' report
1
Balance sheet
2
Statement of changes in equity
3
Notes to the financial statements
4 - 10
GUILDHEALTH LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 1 -

The directors present their annual report and financial statements for the year ended 30 September 2024.

Principal activities

The principal activity of the company continued to be that of management consultancy.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

A J Fowles
D J Hudson
B J Jenkins
D Butler
Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;

- make judgements and accounting estimates that are reasonable and prudent;

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
D J Hudson
Director
16 June 2025
GUILDHEALTH LIMITED
BALANCE SHEET
AS AT
30 SEPTEMBER 2024
30 September 2024
- 2 -
2024
2023
Notes
£
£
£
£
Current assets
Debtors
5
32,328
24,829
Cash at bank and in hand
36,524
82,150
68,852
106,979
Creditors: amounts falling due within one year
6
(27,827)
(23,643)
Net current assets
41,025
83,336
Creditors: amounts falling due after more than one year
7
(6,984)
(13,747)
Net assets
34,041
69,589
Capital and reserves
Called up share capital
8
13
13
Profit and loss reserves
34,028
69,576
Total equity
34,041
69,589

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 16 June 2025 and are signed on its behalf by:
D J Hudson
Director
Company Registration No. 08312723
GUILDHEALTH LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 3 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 October 2022
13
57,534
57,547
Year ended 30 September 2023:
Profit and total comprehensive income for the year
-
77,237
77,237
Dividends
-
(65,195)
(65,195)
Balance at 30 September 2023
13
69,576
69,589
Year ended 30 September 2024:
Loss and total comprehensive income for the year
-
(2,165)
(2,165)
Dividends
-
(33,383)
(33,383)
Balance at 30 September 2024
13
34,028
34,041
GUILDHEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 4 -
1
Accounting policies
Company information

Guildhealth Limited is a private company limited by shares incorporated in England and Wales. The registered office is 128 Buckingham Palace Road, London, United Kingdom, SW1W 9SA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

Disclosure exemption

Exemption has been taken from preparing a cash flow statement on the grounds that the company is considered to be small under the provisions of the Companies Act 2006.

1.2
Going concern

The company has the continued support of the parent company and fellow subsidiaries for any future funding requirements should that be necessary. The directors have a reasonable expectation that the company will have sufficient funds to continue to meet its liabilities as they fall due for the foreseeable future and have therefore prepared the accounts on a going concern basis.true

1.3
Turnover

Turnover represents management fees and recharged costs, excluding Value Added Tax.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

GUILDHEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2024
1
Accounting policies
(Continued)
- 5 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

GUILDHEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2024
1
Accounting policies
(Continued)
- 6 -
1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Bad debt provision

Bad debts are provided for specific debts when required.

3
Auditor's remuneration
2024
2023
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the company
7,000
6,500

The cost of the audit of these financial statements has been met by the parent company.

4
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
1
1
GUILDHEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 7 -
5
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
15,961
9,831
Amounts owed by group undertakings
189
1,681
Other debtors
16,178
13,317
32,328
24,829
6
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans
6,763
6,596
Trade creditors
378
-
0
Amounts owed to group undertakings
1,170
9,955
Corporation tax
12,366
-
0
Other taxation and social security
4,974
5,229
Other creditors
2,176
1,863
27,827
23,643
7
Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
6,984
13,747

The company entered into a £33,000 Bounce Back Loan with HBSC on 3 July 2020. The loan is guaranteed by the UK Government under the Bounce Back Loan Scheme (BBLS) guarantee.

The loan is repayable over 72 months and the first repayment 13 months from the date of the drawdown. Interest is charged at 2.5%

GUILDHEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 8 -
8
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
12
12
12
12
Ordinary - A of £1 each
1
1
1
1
13
13
13
13

All shares rank pari passu and have full voting rights and are entitled to participate in any capital distribution of the company (including on winding up). They do not confer rights of redemption. Both classes of shares are entitled to receive dividends but the company has the right to differentiate between the classes of share as to the time and amount or percentage of dividend payable to each class.

Called up share capital - this represents the nominal value of shares that have been issued.

9
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:

The auditor's report was unqualified.

Senior Statutory Auditor:
Rebecca Boys
Statutory Auditor:
Azets Audit Services
10
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

GUILDHEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2024
10
Related party transactions
(Continued)
- 9 -

Guildhouse UK Limited

During the year, the company was charged management fees of £1,170 (20 23: £9,955) and recharged insurance costs of £370 (2023: £92) from Guildhouse UK Limited, the parent company. At the balance sheet date the company owed £1,170 (20 23: £9,955) to Guildhouse UK Limited.

Assemble Community Partnership Limited

During the year, the company invoiced fees of £nil (20 23: £650) to Assemble Community Partnership Limited, a company under the control of Guildhouse UK Limited.

During the year, the company paid management fees in respect of the surrender of group losses totalling £206 (2023: £nil) to Assemble Community Partnership Limited. Assemble Community Partnership Limited is a subsidiary of Guildhouse UK Limited.

Norlife Capital Works Limited

During the year, the company invoiced fees of £19,944 (20 23: £69,137) to Norlife Capital Works Limited, a company under the control of Guildhouse UK Limited.

Norlife Services Limited

During the year, the company invoiced fees of £nil (2023: £1,000) to Norlife Services Limited, a company under the control of Guildhouse UK Limited.

Norlife Fundco 1 Limited

During the year, the company invoiced fees of £831 (2023: £nil) to Norlife Fundco 1 Limited, a company under the control of Guildhouse UK Limited. At the balance sheet date, the company was owed £189 (20 23: £nil) Norlife Fundco 1 Limited.

Assemble Fundco 1 Limited

During the year, the company the company paid management fees in respect of the surrender of group losses totalling £10,452 (2023: £nil) to Assemble Fundco 1 Limited. Assemble Fundco 1 Limited is a subsidiary company of Assemble Community Partnership Limited, which is a subsidiary of Guildhouse UK (PPP) Limited an intermediate parent company.

Assemble Fundco 2 Limited

During the year, the company paid management fees in respect of the surrender of group losses totalling £14,481 (2023: £nil) to Assemble Fundco 2 Limited. Assemble Fundco 2 Limited is a subsidiary company of Assemble Community Partnership Limited, which is a subsidiary of Guildhouse UK (PPP) Limited an intermediate parent company.

Wolverton Fundco 1 Limited

During the year, the company paid management fees in respect of the surrender of group losses totalling £631 (2023: £nil) to Wolverton Fundco 1 Limited. Wolverton Fundco 1 Limited is a subsidiary company of Assemble Community Partnership Limited, which is a subsidiary of Guildhouse UK (PPP) Limited an intermediate parent company.

11
Parent company and ultimate controlling party

The company is a subsidiary of Guildhouse UK Limited, a company registered in England and Wales.

The results of the company are included in the consolidated financial statements of Guildhouse Holdings Limited, the parent company of Guildhouse UK Limited. The consolidated financial statements are available from Companies House, Crown Way, Cardiff, CF14 3UZ.

Mr D J Hudson, a director, is considered to be the ultimate controlling party of Guildhouse Holdings Limited.

GUILDHEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 10 -
12
Directors' transactions

Dividends totalling £33,383 (2023: £65,195) were paid in the year in respect of shares held by the company's directors.

At the balance sheet date, the company owed £378 (2023: £145) to Mr D Butler.

2024-09-30 2023-10-01 false false false 20 June 2025 CCH Software CCH Accounts Production 2025.100 The principal activity of the company continued to be that of management consultancy.A J Fowles D J Hudson B J Jenkins D Butler 08312723 2023-10-01 2024-09-30 08312723 bus:Director1 2023-10-01 2024-09-30 08312723 bus:Director2 2023-10-01 2024-09-30 08312723 bus:Director3 2023-10-01 2024-09-30 08312723 bus:Director4 2023-10-01 2024-09-30 08312723 bus:RegisteredOffice 2023-10-01 2024-09-30 08312723 2024-09-30 08312723 2023-09-30 08312723 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 08312723 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 08312723 core:Non-currentFinancialInstruments core:AfterOneYear 2024-09-30 08312723 core:Non-currentFinancialInstruments core:AfterOneYear 2023-09-30 08312723 core:CurrentFinancialInstruments 2024-09-30 08312723 core:CurrentFinancialInstruments 2023-09-30 08312723 core:ShareCapital 2024-09-30 08312723 core:ShareCapital 2023-09-30 08312723 core:RetainedEarningsAccumulatedLosses 2024-09-30 08312723 core:RetainedEarningsAccumulatedLosses 2023-09-30 08312723 core:ShareCapital 2022-09-30 08312723 core:RetainedEarningsAccumulatedLosses 2022-09-30 08312723 core:ShareCapitalOrdinaryShareClass1 2024-09-30 08312723 core:ShareCapitalOrdinaryShareClass1 2023-09-30 08312723 core:ShareCapitalOrdinaryShareClass2 2024-09-30 08312723 core:ShareCapitalOrdinaryShareClass2 2023-09-30 08312723 core:ShareCapitalOrdinaryShares 2024-09-30 08312723 core:ShareCapitalOrdinaryShares 2023-09-30 08312723 core:RetainedEarningsAccumulatedLosses 2022-10-01 2023-09-30 08312723 2022-10-01 2023-09-30 08312723 core:RetainedEarningsAccumulatedLosses 2023-10-01 2024-09-30 08312723 core:WithinOneYear 2024-09-30 08312723 core:WithinOneYear 2023-09-30 08312723 core:Non-currentFinancialInstruments 2024-09-30 08312723 core:Non-currentFinancialInstruments 2023-09-30 08312723 bus:OrdinaryShareClass1 2023-10-01 2024-09-30 08312723 bus:OrdinaryShareClass2 2023-10-01 2024-09-30 08312723 bus:OrdinaryShareClass1 2024-09-30 08312723 bus:OrdinaryShareClass1 2023-09-30 08312723 bus:OrdinaryShareClass2 2024-09-30 08312723 bus:OrdinaryShareClass2 2023-09-30 08312723 bus:AllOrdinaryShares 2024-09-30 08312723 bus:AllOrdinaryShares 2023-09-30 08312723 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 08312723 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 08312723 bus:FRS102 2023-10-01 2024-09-30 08312723 bus:Audited 2023-10-01 2024-09-30 08312723 bus:FullAccounts 2023-10-01 2024-09-30 xbrli:pure xbrli:shares iso4217:GBP